Private Label Tranexamic & Kojic Acid Body Lotion Low MOQ

The minimum order quantity for a private label tranexamic acid and kojic acid body lotion depends primarily on whether you're working with a stock formula or commissioning a custom development. Stock or white-label formulas — where the manufacturer already has a base formula with these actives blended — typically carry MOQs of 200 to 500 units. Custom-developed formulas, where a cosmetic chemist tailors the active percentages, emollient system, and sensory profile to your spec, usually start at 500 to 2,000 units because of the additional R&D investment the manufacturer has to recoup. Several factors push MOQs up or down. Packaging choice is one of the biggest levers: a standard stock airless pump bottle the manufacturer already runs will have the lowest MOQ, while a bespoke frosted tube with a custom closure can double or triple the floor because of tooling costs. Fill size matters too — a 250ml lotion in a commodity tube is far easier to run at 200 units than a 500ml bottle with specialty printing. Geography is another variable. Manufacturers based in China and South Korea often accommodate 200-unit runs with competitive unit costs because they run multi-brand batches. US-based and EU-based manufacturers producing under ISO 22716 GMP typically set their floor at 500 to 1,000 units due to higher labor and raw material costs, though some specialty small-batch labs go as low as 100 units at a premium. Active-ingredient formulations like TXA and kojic acid add a layer of complexity that some low-MOQ manufacturers aren't set up for. You need a partner who has run stability testing on kojic acid-containing emulsions specifically, because kojic acid is notoriously prone to oxidation and color change. If a manufacturer hasn't done that work before, they'll either refuse the project or require a higher MOQ to justify building the capability. The common mistake first-time founders make is accepting the lowest advertised MOQ without asking whether stability data, a certificate of analysis, and preservative efficacy testing are included at that volume. A 200-unit run with no supporting documentation is essentially an untested cosmetic — it can't be sold into retail and exposes your brand to regulatory liability. AJ Cosmo Labs allows you to filter manufacturers by MOQ before you ever send an inquiry, so you're only talking to partners who can meet your volume. Post your brief on the app, specify your target MOQ, and receive qualified responses from vetted cosmetic contract manufacturers within days.

The total cost of bringing a private label kojic acid and tranexamic acid body lotion to market breaks into three buckets: formula or R&D costs, unit production costs, and ancillary costs like testing, regulatory, and packaging artwork. For stock formula private label — where you apply your brand to an existing formula — R&D fees are minimal, usually $0 to $500 as a one-time setup or logo application fee. Unit production costs at 500 units typically land between $4 and $8 per unit for a standard 200ml to 250ml body lotion. That range reflects the cost uplift for active ingredients: tranexamic acid is a pharmaceutical-grade raw material that carries a higher raw material cost than basic emollients, and kojic acid in cosmetic-grade purity adds to the bill as well. At 1,000 units, unit costs generally fall to $3.50 to $6.50 as batch economics improve. For custom-developed formulas, expect to pay a development fee of $1,500 to $8,000 depending on the number of iterations your cosmetic chemist goes through, whether they're building a new formula from scratch or adapting an existing base, and whether the manufacturer conducts stability and compatibility testing in-house or outsources it. Production costs per unit for a custom formula at 500 units are typically $7 to $14, again depending on active concentrations, packaging, and geography of the manufacturer. Stability testing — mandatory for any responsible launch — adds $500 to $2,500 if it's not bundled into the manufacturer's offer. A 3-month accelerated stability study aligned with ICH Q1A guidelines is the minimum you should accept. Real-time stability data at 12 months is what major retail buyers like Ulta or Target require before onboarding a new SKU. Preservative efficacy testing (challenge testing per USP 51 or ISO 11930) adds another $300 to $800 if charged separately. Some manufacturers bundle this into their standard active-formula service. Packaging is a major cost variable. Commodity airless pumps for a brightening lotion — which formulators recommend to minimize oxidation exposure — run $0.40 to $1.20 per unit at 500 units. Custom-printed or bespoke packaging can push that to $2 to $4+ per unit plus tooling fees of $1,500 to $5,000. Regulatory documentation — Safety Assessment for EU markets, Cosmetic Notification Form for Canada, CPNP for the EU — adds $500 to $3,000 depending on how many markets you're entering simultaneously. A realistic all-in budget for a 500-unit first run of a stock formula TXA + kojic acid lotion with modest packaging is $5,000 to $10,000. A custom-developed formula at the same volume with full testing runs $12,000 to $25,000. These are real-world ranges, not worst-case scenarios — plan accordingly.

The lead time for a private label tranexamic acid and kojic acid body lotion follows a predictable sequence of stages, and understanding each stage helps you plan your launch calendar realistically. For a stock formula private label, the timeline from contract signing to finished goods in your warehouse is typically 6 to 10 weeks. That breaks down as: 1 to 2 weeks for paperwork, formula review, and label artwork approval; 2 to 3 weeks for a pilot or pre-production batch if the manufacturer requires one; 1 to 2 weeks for quality control and certificate of analysis sign-off; and 1 to 2 weeks for shipping depending on whether goods are moving domestically or internationally. For custom formulation development, add 8 to 12 weeks to the front end. A cosmetic chemist will typically produce 2 to 4 formula prototypes before reaching a benchmark you approve. Each iteration requires internal stability assessment before it's sent to you for sensory evaluation. Once you approve a prototype, a stability study begins — accelerated stability at 40°C/75% RH runs a minimum of 8 to 12 weeks. You can begin production on early stability data with a risk acknowledgment, but most founders wait for 3-month data before a commercial run. Total custom timeline: 16 to 24 weeks from project kickoff to delivery for a first batch. Experienced founders who have done this before often compress it to 14 to 18 weeks by pre-selecting packaging, providing a detailed brief, and making fast decisions on prototype feedback. The common mistake is underestimating the stability testing phase. Kojic acid is one of the more demanding actives to stabilize in an aqueous emulsion — it oxidizes and turns the product orange or brown if the chelating agent, antioxidant system, or pH buffer isn't right. Rushing past stability data to hit a launch date is how brands end up with returned inventory and a reformulation bill. Shipping lead times add to total timelines if you're importing from overseas manufacturers. Sea freight from China or Korea to the US typically runs 3 to 5 weeks; air freight 5 to 10 business days. Factor in customs clearance of 3 to 10 business days as well. Using AJ Cosmo Labs to post your brief and receive manufacturer responses in parallel — rather than sequentially approaching suppliers one by one — can shave 2 to 4 weeks off your total sourcing timeline alone.

Kojic acid is legally permitted as a cosmetic ingredient in the United States under FDA jurisdiction, where it is considered a cosmetic (not a drug) as long as no drug claims are made. The FDA does not pre-approve cosmetic formulas, so kojic acid body lotions can be sold in the US without regulatory pre-clearance, provided the product is properly labeled with an accurate INCI ingredient list and no claims are made suggesting it treats, prevents, or cures a disease or skin condition. In the European Union, the situation is more nuanced. Kojic acid was evaluated by the EU's Scientific Committee on Consumer Safety (SCCS). The SCCS issued an opinion that kojic acid is safe for use in face products at concentrations up to 1% and body products at up to 1% as well, under the condition that the product does not result in systemic exposure exceeding a certain threshold. As of the current regulatory landscape, kojic acid is permitted in EU cosmetics at these concentrations, but it is on the watch list for further restriction, so formulators targeting the EU market keep concentrations at or below 1% in leave-on products to stay well inside safety margins. Products sold into the EU also require a full Safety Assessment by a qualified assessor (a toxicologist or cosmetic chemist with the appropriate qualifications) and a Product Information File. In the UK post-Brexit, the Cosmetics Regulation (EU) No 1223/2009 has been retained in domestic law. The same concentration guidance applies, and products must be notified through the UK's Office for Product Safety and Standards (OPSS) portal, with a UK Responsible Person designated. In Canada, kojic acid is permitted as a cosmetic ingredient. Manufacturers must submit a Cosmetic Notification Form (CNF) to Health Canada within 10 days of first sale. If any skin-lightening claims are made, Health Canada may scrutinize the product more closely under its drug-cosmetic borderline policy. Transexamic acid has a cleaner regulatory profile across most markets. It is permitted at cosmetic-grade concentrations in the US, EU, UK, Canada, and most ASEAN markets without specific concentration restrictions in leave-on cosmetics as of current guidance. The critical compliance risk area is claims language. Phrases like "eliminates dark spots," "corrects hyperpigmentation," or "treats melasma" can be interpreted as drug claims by regulators in multiple markets, which would reclassify your product and require a completely different approval pathway. Work with a cosmetic regulatory consultant to develop compliant claims such as "visibly brightens the appearance of uneven skin tone" before your artwork is finalized.

The working concentration ranges for tranexamic acid and kojic acid in a body lotion are driven by a combination of efficacy evidence, stability constraints, and regulatory limits, and they differ meaningfully between the two actives. Transexamic acid (TXA) is used in cosmetic formulations at concentrations ranging from 2% to 5%. Most published in-vitro and clinical studies supporting TXA's brightening mechanism used concentrations in the 2% to 3% range for topical applications. Some manufacturers formulate at up to 5% for a more aggressive efficacy positioning, though there is no regulatory cap on TXA concentration in cosmetics in major markets as of current guidance. Below 2%, consumer-perceptible efficacy is questionable; above 5%, the incremental benefit is unclear and the cost per unit increases significantly because TXA is a pharmaceutical-grade raw material. Kojic acid presents more constraints. The SCCS-informed guideline for leave-on products in the EU is ≤1%. For the US market, there is no regulatory cap, and concentrations of 1% to 2% are common in commercial products. Most formulators working on a globally exportable product set kojic acid at exactly 1% to comply with the most restrictive applicable market (EU) while still delivering efficacy. At concentrations above 2%, there is a meaningful risk of irritation and sensitization, especially on abraded or sun-damaged skin — the kind of skin that brightening body lotion customers typically have. Stability is the second reason to keep kojic acid concentration conservative. Higher concentrations of kojic acid in an aqueous emulsion increase the risk of visible discoloration (the product turning orange, yellow, or brown) if the antioxidant and chelation system isn't perfectly calibrated. A cosmetic chemist will typically add sodium metabisulfite or ascorbic acid as an antioxidant and EDTA as a chelating agent to protect kojic acid from oxidative degradation. The finished product pH should be maintained between 4.5 and 5.5 — above pH 6, kojic acid stability drops sharply. Niacinamide is commonly added as a third brightening agent at 2% to 5%, which gives the formula a triple-mechanism story without adding regulatory complexity. However, formulators must test the TXA + kojic acid + niacinamide combination for compatibility — niacinamide can form a niacin complex with certain ingredients that causes facial flushing, though this is less of a concern in body lotion rinse-off or leave-on contexts at these concentrations. The practical recommendation for a first-time formulation: start at TXA 2%, kojic acid 1%, niacinamide 3%, and run a full stability and PET study before committing to a commercial batch. Adjust actives upward in future iterations based on stability results and consumer feedback.

Finding a cosmetic contract manufacturer who is genuinely set up for active-ingredient formulations at low minimum order quantities requires more than a Google search — the manufacturers who advertise MOQs of 100 units on generic directories are rarely equipped to handle the stability, regulatory, and technical demands of a dual-active brightening lotion. The most reliable approach is to start with a clearly written product brief before you contact anyone. Your brief should specify: target formula type (lotion, cream, serum-lotion hybrid), active ingredients and approximate concentrations (TXA at 2–5%, kojic acid at 1%), target fill volume, packaging preference (airless pump recommended for oxidation-sensitive formulas), intended markets (US-only, US + EU, global), desired MOQ, and timeline. A manufacturer who responds to a detailed brief with a thoughtful proposal — rather than a generic price list — is a signal of real capability. Key vetting questions to ask every candidate: Do you have existing stability data on kojic acid-containing leave-on emulsions? Can you share a redacted certificate of analysis from a similar product? Are you ISO 22716 certified or equivalent? Do you run preservative efficacy testing in-house or outsource? What is your typical lead time from formula approval to finished goods? Do you have experience exporting to EU or UK markets and can you provide compliance documentation? Disqualifying signals include: inability to provide a Certificate of Analysis template, no mention of preservative challenge testing, vague or absent stability testing protocols, and unwillingness to provide a manufacturing agreement or quality agreement before production. Regional considerations matter. US-based manufacturers offer supply chain security and easier communication but generally carry higher unit costs. South Korean manufacturers have deep expertise in brightening actives — Korea is arguably the global leader in tranexamic acid skincare development — and often have competitive pricing with robust GMP infrastructure. Chinese manufacturers vary enormously in quality; tier-1 ISO 22716-certified facilities in Guangzhou or Shanghai are excellent, but due diligence is essential. AJ Cosmo Labs was built specifically to solve this sourcing problem. The iOS app lets you post a single product brief and receive responses from pre-screened cosmetic contract manufacturers who have already been evaluated for GMP compliance, active-ingredient experience, and low-MOQ capability. You can filter by MOQ, geography, and specialization, message suppliers directly in-app, manage sample tracking, and release milestone payments through escrow — all without leaving the platform. Download AJ Cosmo Labs from the App Store to start connecting with the right manufacturing partner for your brightening body lotion.

Packaging selection for a kojic acid and tranexamic acid body lotion is not purely an aesthetic decision — it directly affects the shelf life, stability, and regulatory defensibility of your product, and getting it wrong can cost you an entire batch. Kojic acid is highly susceptible to oxidation when exposed to air and light. This means clear or translucent packaging — including standard clear PET bottles — poses a real risk of visible product discoloration (yellowing or browning) over time, especially if the product sits near a window or under retail display lighting. The primary packaging recommendation from most cosmetic formulators is an opaque, airless pump dispenser. Airless pumps prevent oxygen from re-entering the bottle after each use, dramatically reducing oxidative degradation between uses. Opaque or UV-barrier materials protect against photo-oxidation. If airless pumps are out of budget for your MOQ, the next best options are opaque HDPE bottles with a disc cap or a lotion pump, or laminate tubes with a UV-barrier layer. Avoid glass for body lotion in the brightening category unless you're in a luxury positioning — glass is heavy, breakage-prone in bathrooms, and offers no inherent barrier against oxygen ingress via the cap. For secondary packaging (outer carton), including a UV-resistant coating on the carton adds a minor cost but meaningfully protects the primary container during retail shelf display. Fill size considerations: body lotion is typically sold in 200ml, 250ml, or 300ml formats in the brightening category. Larger formats (400ml+) are gaining traction in value-positioning DTC brands targeting consumers who use body lotion daily over large surface areas. The fill size you choose affects your per-unit cost and your price positioning — a 250ml airless pump at a $22–$35 retail price point is where most indie brightening body lotion brands land in the mid-market segment. Silicone-lined closures are worth specifying if you're using a standard pump — they provide a better seal and reduce the micro-air ingress that standard plastic-to-plastic closures allow. From a regulatory standpoint, the EU requires that packaging be evaluated as part of the product's compatibility testing. Your contract manufacturer should run a product-in-package compatibility study — confirming that the primary packaging material doesn't leach into the formula and that the active ingredients remain stable in contact with the chosen material over the stated shelf life. This is especially important with kojic acid, which can react with certain metal components in pumps if a stainless-steel spring is not specified. The AJ Cosmo Labs app includes packaging designers and component suppliers in its marketplace alongside cosmetic manufacturers, so you can coordinate formula and packaging sourcing in one place.